| Drug Class | GLP-1 Receptor Agonist | Dual GIP and GLP-1 Receptor Therapy |
|---|
| Care Context | Medically supervised weight-management care for eligible adults | Medically supervised weight-management care for eligible adults |
|---|
| Clinical Evaluation | Independent licensed clinician review via asynchronous or video consult | Independent licensed clinician review via asynchronous or video consult |
|---|
| Regulatory Status | Compounded drug product: Not FDA-approved; not reviewed by the FDA for safety, effectiveness, or quality | Compounded drug product: Not FDA-approved; not reviewed by the FDA for safety, effectiveness, or quality |
|---|
| Prescription Requirement | Prescription required; an intake or payment does not guarantee a prescription | Prescription required; an intake or payment does not guarantee a prescription |
|---|
| Dispensing Pharmacies | State-licensed U.S. compounding pharmacies: Rush Pharmacy or Epiq Scripts | State-licensed U.S. compounding pharmacies: Rush Pharmacy or Epiq Scripts |
|---|
| Fulfillment Format | Prepared for an individual patient pursuant to a valid prescription; shipped discreetly | Prepared for an individual patient pursuant to a valid prescription; shipped discreetly |
|---|